Co-Authors
This is a "connection" page, showing publications co-authored by Feixiong Cheng and Yadi Zhou.
Connection Strength
4.333
-
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res Ther. 2021 06 09; 13(1):110.
Score: 0.950
-
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol. 2020 11; 18(11):e3000970.
Score: 0.912
-
Artificial intelligence in COVID-19 drug repurposing. Lancet Digit Health. 2020 12; 2(12):e667-e676.
Score: 0.903
-
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020; 6:14.
Score: 0.872
-
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19. Signal Transduct Target Ther. 2021 07 30; 6(1):292.
Score: 0.240
-
The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation. Front Neurosci. 2021; 15:606926.
Score: 0.233
-
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning. J Proteome Res. 2020 11 06; 19(11):4624-4636.
Score: 0.223